A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Dr James Lavers is part of the first coordinated group of NHS volunteers to be deployed by the UK Government.
Helen Plint has the latest weather forecast for Wales.
Dan Biggar has highlighted standards Wales must reach in their quest to end 61 years of hurt against world champions New Zealand.